The Effect of Family Integrated Care on Melatonin Level in Very Low Birth Weight Infants
Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · Aug 1, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how Family Integrated Care (FICare) can affect melatonin levels and other health outcomes in very low birth weight infants (those who weigh less than 3.3 pounds at birth). FICare means that families will be actively involved in their baby's care while they are in the neonatal intensive care unit (NICU). This study aims to see if having parents participate in daily care helps both the babies and the parents.
To be eligible for this study, babies must weigh less than 1,500 grams (about 3.3 pounds) and be born before 32 weeks of pregnancy. Parents need to be able to cooperate and willing to take part in training to care for their baby for at least 6 hours a day over a span of 21 days. It's important to note that babies who need special treatments or have certain health problems will not be included in the trial. If you choose to participate, you can expect to learn how to care for your baby while also contributing to important research that could improve care for future infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Birth weight \< 1500g;
- • Gestational age \< 32w;
- • Admit within 24 hours of birth;
- • The parents are conscious and able to cooperate, have certain learning and reading comprehension skills, and are capable of caring for their babies. They are committed to receiving training and caring for their babies for not less than 6 hours a day for at least 21 days;
- • Voluntarily participate in this study and sign informed consent.
- • Exclusion Criteria
- • Newborns who require palliative care or surgical intervention;
- • OI (oxygenation index) \<300 ;
- • Newborns with severe congenital malformations;
About Children's Hospital Of Fudan University
The Children's Hospital of Fudan University is a leading pediatric healthcare institution in China, renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on conducting high-quality, ethically-driven studies that aim to improve pediatric care and treatment outcomes. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital leverages its robust infrastructure and expertise to facilitate groundbreaking clinical trials, ensuring the safety and well-being of child participants while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Xiaojing Hu, PhD
Principal Investigator
Children's Hospital of Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials